Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    Conference Program for 2022 the World Conference on Lung Cancer

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2137

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    IS05 - Industry Symposium Sponsored by Merck Kgaa Darmstadt: Decisive Moments in the Treatment of MET exon 14 Skipping NSCLC

    • 13:15 - 14:15
    • 8/06/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Industry Symposium
    • Track: N/A
    • +

      IS05.03 - A Moment of Clarity: Has Our VISION1 for METex14 Skipping Become A Reality?

      13:25 - 13:40  |  Presenter: Paul Paik

      • Abstract

      Loading...

    • +

      IS05.04 - Seize the Moment: The Benefits of Early Treatment

      13:40 - 13:55  |  Presenter: Paul Paik

      • Abstract

      Loading...

  • +

    OA03 - Molecular Targeted Treatments

    • 14:30 - 15:40
    • 8/07/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      OA03.05 - Tepotinib in Patients with MET Exon 14 (METex14) Skipping NSCLC: Primary Analysis of the Confirmatory VISION Cohort C

      14:52 - 15:02  |  Presenter: Michael Thomas

      • Abstract

      Loading...

  • +

    MA13 - Update on ROS1 Inhibitors and New Pathways

    • 12:00 - 13:00
    • 8/09/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      MA13.08 - A Phase 1 Trial of Sapanisertib and Telaglenastat (CB-839) in Patients With Advanced NSCLC (NCI 10327): Results from Dose Escalation

      12:32 - 12:37  |  Presenter: Jonathan Riess

      • Abstract

      Loading...